sellWeak cluster of 410b5-1 plan
Swisher Daniel N JR sold $132k of CORT
director at CORCEPT THERAPEUTICS INC. 2,200 shares at an average of $59.88, traded Nov 11, 2024, filed Nov 13, 2024.
Warning score
26Value
$132k
2,200 shares
Holdings after
0
-100% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-126625, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 11, 2024 | MOption exercise Common Stock10b5-1 | +2,200 | $12.13 | $27k | 2,200 | Nov 13, 2024 |
| Nov 11, 2024 | SOpen-market sale Common Stock10b5-1 | -2,200 | $59.88 | $132k | 0 | Nov 13, 2024 |
| Nov 11, 2024 | MOption exercise Stock option (right to buy)derivative10b5-1 | -2,200 | $0.00 | $0 | 12,800 | Nov 13, 2024 |
Related signals
Other insiders at CORCEPT THERAPEUTICS INC and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 11Weak | sell10b5-1 | CORT CORCEPT THERAPEUTICS INC | Swisher Daniel N JR director | $131k | 2,200 | |
| 44Moderate | sell 3 | CORT CORCEPT THERAPEUTICS INC | Lyon Joseph Douglas See Remarks | $80k | 1,411 | |
| 46Moderate | sell 3 | CORT CORCEPT THERAPEUTICS INC | Robb Gary Charles Chief Business Officer | $147k | 2,609 | |
| 26Weak | sell 210b5-1 | CORT CORCEPT THERAPEUTICS INC | Guyer William Chief Development Officer | $490k | 10,000 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.